228 related articles for article (PubMed ID: 15964087)
1. Risk stratification for arrhythmic death after myocardial infarction: current perspective and future direction.
Arya A; Haghjoo M; Sadr-Ameli MA
Int J Cardiol; 2006 Apr; 108(2):155-64. PubMed ID: 15964087
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification for sudden death in heart failure.
Farwell D; Gollob MH
Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
5. [Arrhythmia risk stratification in patients with heart failure. Foreword].
Opasich C; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
[TBL] [Abstract][Full Text] [Related]
6. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
Lombardi F
Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
8. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
10. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
Dagres N; Hindricks G
Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
[TBL] [Abstract][Full Text] [Related]
12. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
[TBL] [Abstract][Full Text] [Related]
13. [New aspects of ICD therapy: from rhythm therapy to complex cardiac monitoring. Development of an implantable, ICD-assisted, intrathoracic 6-channel ECG for continuous monitoring of high infarct risk patients].
Grom A; Zehender M
Biomed Tech (Berl); 2002 Oct; 47(9-10):234-8. PubMed ID: 12369210
[TBL] [Abstract][Full Text] [Related]
14. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
15. Decision to implant a cardioverter defibrillator after myocardial infarction: the role of ejection fraction v. other risk factor markers.
Bailey JJ; Hodges M; Church TR
Med Decis Making; 2007; 27(2):151-60. PubMed ID: 17409365
[TBL] [Abstract][Full Text] [Related]
16. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
19. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
[TBL] [Abstract][Full Text] [Related]
20. [How to evaluate sudden cardiac death risk after myocardial infarction?].
Marijon E; Boveda S; Combes N; Albenque JP; Le Heuzey JY
Ann Cardiol Angeiol (Paris); 2009 Aug; 58(4):220-5. PubMed ID: 18937927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
